Search

Your search keyword '"Aparicio, Ana"' showing total 958 results
Start Over Author "Aparicio, Ana"
958 results on '"Aparicio, Ana"'

2. Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2.

Author

Bryce, Alan, Crawford, E, Agarwal, Neeraj, Hussain, Maha, Beltran, Himisha, Cooperberg, Matthew, Petrylak, Daniel, Shore, Neal, Spratt, Daniel, Tagawa, Scott, Antonarakis, Emmanuel, Aparicio, Ana, Armstrong, Andrew, Boike, Thomas, Calais, Jeremie, Carducci, Michael, Chapin, Brian, Cookson, Michael, Davis, John, Dorff, Tanya, Eggener, Scott, Feng, Felix, Gleave, Martin, Higano, Celestia, Iagaru, Andrei, Morgans, Alicia, Morris, Michael, Murray, Katie, Poage, Wendy, Rettig, Matthew, Sartor, Oliver, Scher, Howard, Sieber, Paul, Small, Eric, Srinivas, Sandy, Yu, Evan, Zhang, Tian, and Koo, Phillip

Subjects
androgen antagonists, biomarkers, precision medicine, prostatic neoplasms, radiotherapy
Abstract

BACKGROUND: Management strategies for metastatic castration-resistant prostate cancer (mCRPC) have rapidly shifted in recent years. As novel imaging and therapeutic approaches have made their way to the clinic, providers are encountering increasingly challenging clinical scenarios, with limited guidance from the current literature. MATERIALS AND METHODS: The US Prostate Cancer Conference (USPCC) is a multidisciplinary meeting of prostate cancer experts intended to address the many challenges of prostate cancer management. At the first annual USPCC meeting, areas of controversy and consensus were identified during a 2-day meeting that included expert presentations, full-panel discussions, and postdiscussion responses to questions developed by the USPCC cochairs and session moderators. RESULTS: This narrative review covers the USPCC expert discussion and perspectives relevant to mCRPC, including neuroendocrine/aggressive-variant prostate cancer (NEPC/AVPC). Areas of broad agreement identified among USPCC experts include the benefits of poly (ADP-ribose) polymerase (PARP) inhibitors for patients with BRCA1/2 mutations, the use of radioligand therapy in patients with prostate-specific membrane antigen (PSMA)-positive mCRPC, and the need for clinical trials that address real-world clinical questions, including the performance of novel therapies when compared with modern standard-of-care treatment. Ongoing areas of controversy and uncertainty included the appropriateness of PARP inhibitors in patients with non-BRCA1/2 mutations, the optimal definition of PSMA positivity, and systemic therapies for patients with NEPC/AVPC after progression on platinum-based therapies. CONCLUSIONS: The first annual USPCC meeting identified several areas of controversy in the management of mCRPC, highlighting the urgent need for clinical trials designed to facilitate treatment selection and sequencing in this heterogeneous disease state.

Published
2024

3. Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1.

Author

Crawford, E, Bryce, Alan, Hussain, Maha, Agarwal, Neeraj, Beltran, Himisha, Cooperberg, Matthew, Petrylak, Daniel, Shore, Neal, Spratt, Daniel, Tagawa, Scott, Antonarakis, Emmanuel, Aparicio, Ana, Armstrong, Andrew, Boike, Thomas, Calais, Jeremie, Carducci, Michael, Chapin, Brian, Cookson, Michael, Davis, John, Dorff, Tanya, Eggener, Scott, Feng, Felix, Gleave, Martin, Higano, Celestia, Iagaru, Andrei, Morgans, Alicia, Morris, Michael, Murray, Katie, Poage, Wendy, Rettig, Matthew, Sartor, Oliver, Scher, Howard, Sieber, Paul, Small, Eric, Srinivas, Sandy, Yu, Evan, Zhang, Tian, and Koo, Phillip

Subjects
biomarkers, ndrogen antagonists, precision medicine, prostatic neoplasms, radiotherapy
Abstract

PURPOSE: Castration-sensitive prostate cancer (CSPC) is a complex and heterogeneous condition encompassing a range of clinical presentations. As new approaches have expanded management options, clinicians are left with myriad questions and controversies regarding the optimal individualized management of CSPC. MATERIALS AND METHODS: The US Prostate Cancer Conference (USPCC) multidisciplinary panel was assembled to address the challenges of prostate cancer management. The first annual USPCC meeting included experts in urology, medical oncology, radiation oncology, and nuclear medicine. USPCC co-chairs and session moderators identified key areas of controversy and uncertainty in prostate cancer management and organized the sessions with multidisciplinary presentations and discussion. Throughout the meeting, experts responded to questions prepared by chairs and moderators to identify areas of agreement and controversy. RESULTS: The USPCC panel discussion and question responses for CSPC-related topics are presented. Key advances in CSPC management endorsed by USPCC experts included the development and clinical utilization of gene expression classifiers and artificial intelligence (AI) models for risk stratification and treatment selection in specific patient populations, the use of advanced imaging modalities in patients with clinically localized unfavorable intermediate or high-risk disease and those with biochemical recurrence, recommendations of doublet or triplet therapy for metastatic CSPC (mCSPC), and consideration of prostate and/or metastasis-directed radiation therapy in select patients with mCSPC. CONCLUSIONS: CSPC is a diverse disease with many therapeutic options and the potential for adverse outcomes associated with either undertreatment or overtreatment. Future studies are needed to validate and clinically integrate novel technologies, including genomics, AI, and advanced imaging, to optimize outcomes among patients with CSPC.

Published
2024

5. Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms

Author

Serrano, Alejandra G., Rocha, Pedro, Freitas Lima, Cibelle, Stewart, Allison, Zhang, Bingnan, Diao, Lixia, Fujimoto, Junya, Cardnell, Robert J., Lu, Wei, Khan, Khaja, Sable, Beate, Ellison, Aaron R., Wistuba, Ignacio I., Concannon, Kyle F., Halperin, Daniel M., Bogdan, Czerniak, Sircar, Kanishka, Zhang, Miao, Cargill, Kasey, Wang, Qi, Aparicio, Ana, Lazar, Alexander, Hernandez, Sharia, Estrella, Jeannelyn, Ramalingam, Preetha, El-Naggar, Adel, Kalhor, Neda, Gay, Carl M., Byers, Lauren Averett, and Solis Soto, Luisa M.

Published
2024
Full Text
View/download PDF

8. Index

Author

Aparicio, Ana

Published
2006

9. Notes

Author

Aparicio, Ana

Published
2006

18. Copyright

Author

Aparicio, Ana

Published
2006

20. Foreword

Author

Aparicio, Ana

Published
2006

24. Title Page

Author

Aparicio, Ana

Published
2006

27. Archival single-cell genomics reveals persistent subclones during DCIS progression

Author

Wang, Kaile, Kumar, Tapsi, Wang, Junke, Minussi, Darlan Conterno, Sei, Emi, Li, Jianzhuo, Tran, Tuan M., Thennavan, Aatish, Hu, Min, Casasent, Anna K., Xiao, Zhenna, Bai, Shanshan, Yang, Lei, King, Lorraine M., Shah, Vandna, Kristel, Petra, van der Borden, Carolien L., Marks, Jeffrey R., Zhao, Yuehui, Zurita, Amado J., Aparicio, Ana, Chapin, Brian, Ye, Jie, Zhang, Jianjun, Gibbons, Don L., Sawyer, Ellinor, Thompson, Alastair M., Futreal, Andrew, Hwang, E. Shelley, Wesseling, Jelle, Lips, Esther H., and Navin, Nicholas E.

Published
2023
Full Text
View/download PDF

28. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

Author

Gillessen, Silke, Bossi, Alberto, Davis, Ian D., de Bono, Johann, Fizazi, Karim, James, Nicholas D., Mottet, Nicolas, Shore, Neal, Small, Eric, Smith, Matthew, Sweeney, Christopher J., Tombal, Bertrand, Antonarakis, Emmanuel S., Aparicio, Ana M., Armstrong, Andrew J., Attard, Gerhardt, Beer, Tomasz M., Beltran, Himisha, Bjartell, Anders, Blanchard, Pierre, Briganti, Alberto, Bristow, Rob G., Bulbul, Muhammad, Caffo, Orazio, Castellano, Daniel, Castro, Elena, Cheng, Heather H., Chi, Kim N., Chowdhury, Simon, Clarke, Caroline S., Clarke, Noel, Daugaard, Gedske, De Santis, Maria, Duran, Ignacio, Eeles, Ross, Efstathiou, Eleni, Efstathiou, Jason, Ekeke, Onyeanunam Ngozi, Evans, Christopher P., Fanti, Stefano, Feng, Felix Y., Fonteyne, Valerie, Fossati, Nicola, Frydenberg, Mark, George, Dan, Gleave, Martin, Gravis, Gwenaelle, Halabi, Susan, Heinrich, Daniel, Herrmann, Ken, Higano, Celestia, Hofman, Michael S., Horvath, Lisa G., Hussain, Maha, Jereczek-Fossa, Barbara A., Jones, Rob, Kanesvaran, Ravindran, Kellokumpu-Lehtinen, Pirkko-Liisa, Khauli, Raja B., Klotz, Laurence, Kramer, Gero, Leibowitz, Raja, Logothetis, Christopher, Mahal, Brandon, Maluf, Fernando, Mateo, Joaquin, Matheson, David, Mehra, Niven, Merseburger, Axel, Morgans, Alicia K., Morris, Michael J., Mrabti, Hind, Mukherji, Deborah, Murphy, Declan G., Murthy, Vedang, Nguyen, Paul L., Oh, William K., Ost, Piet, O’Sullivan, Joe M., Padhani, Anwar R., Pezaro, Carmel J., Poon, Darren M.C., Pritchard, Colin C., Rabah, Danny M., Rathkopf, Dana, Reiter, Robert E., Rubin, Mark A., Ryan, Charles J., Saad, Fred, Sade, Juan Pablo, Sartor, Oliver, Scher, Howard I., Sharifi, Nima, Skoneczna, Iwona, Soule, Howard, Spratt, Daniel E., Srinivas, Sandy, Sternberg, Cora N., Steuber, Thomas, Suzuki, Hiroyoshi, Sydes, Matthew R., Taplin, Mary-Ellen, Tilki, Derya, Türkeri, Levent, Turco, Fabio, Uemura, Hiroji, Uemura, Hirotsugu, Ürün, Yüksel, Vale, Claire L., van Oort, Inge, Vapiwala, Neha, Walz, Jochen, Yamoah, Kosj, Ye, Dingwei, Yu, Evan Y., Zapatero, Almudena, Zilli, Thomas, and Omlin, Aurelius

Published
2023
Full Text
View/download PDF

29. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

Author

Gillessen, Silke, Bossi, Alberto, Davis, Ian D., de Bono, Johann, Fizazi, Karim, James, Nicholas D., Mottet, Nicolas, Shore, Neal, Small, Eric, Smith, Matthew, Sweeney, Christopher, Tombal, Bertrand, Antonarakis, Emmanuel S., Aparicio, Ana M., Armstrong, Andrew J., Attard, Gerhardt, Beer, Tomasz M., Beltran, Himisha, Bjartell, Anders, Blanchard, Pierre, Briganti, Alberto, Bristow, Rob G., Bulbul, Muhammad, Caffo, Orazio, Castellano, Daniel, Castro, Elena, Cheng, Heather H., Chi, Kim N., Chowdhury, Simon, Clarke, Caroline S., Clarke, Noel, Daugaard, Gedske, De Santis, Maria, Duran, Ignacio, Eeles, Ros, Efstathiou, Eleni, Efstathiou, Jason, Ngozi Ekeke, Onyeanunam, Evans, Christopher P., Fanti, Stefano, Feng, Felix Y., Fonteyne, Valerie, Fossati, Nicola, Frydenberg, Mark, George, Daniel, Gleave, Martin, Gravis, Gwenaelle, Halabi, Susan, Heinrich, Daniel, Herrmann, Ken, Higano, Celestia, Hofman, Michael S., Horvath, Lisa G., Hussain, Maha, Jereczek-Fossa, Barbara Alicja, Jones, Robert, Kanesvaran, Ravindran, Kellokumpu-Lehtinen, Pirkko-Liisa, Khauli, Raja B., Klotz, Laurence, Kramer, Gero, Leibowitz, Raya, Logothetis, Christopher J., Mahal, Brandon A., Maluf, Fernando, Mateo, Joaquin, Matheson, David, Mehra, Niven, Merseburger, Axel, Morgans, Alicia K., Morris, Michael J., Mrabti, Hind, Mukherji, Deborah, Murphy, Declan G., Murthy, Vedang, Nguyen, Paul L., Oh, William K., Ost, Piet, O'Sullivan, Joe M., Padhani, Anwar R., Pezaro, Carmel, Poon, Darren M.C., Pritchard, Colin C., Rabah, Danny M., Rathkopf, Dana, Reiter, Robert E., Rubin, Mark. A., Ryan, Charles J., Saad, Fred, Pablo Sade, Juan, Sartor, Oliver A., Scher, Howard I., Sharifi, Nima, Skoneczna, Iwona, Soule, Howard, Spratt, Daniel E., Srinivas, Sandy, Sternberg, Cora N., Steuber, Thomas, Suzuki, Hiroyoshi, Sydes, Matthew R., Taplin, Mary-Ellen, Tilki, Derya, Türkeri, Levent, Turco, Fabio, Uemura, Hiroji, Uemura, Hirotsugu, Ürün, Yüksel, Vale, Claire L., van Oort, Inge, Vapiwala, Neha, Walz, Jochen, Yamoah, Kosj, Ye, Dingwei, Yu, Evan Y., Zapatero, Almudena, Zilli, Thomas, and Omlin, Aurelius

Published
2023
Full Text
View/download PDF

30. Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer

Author

Zhang, Bingnan, Stewart, C. Allison, Wang, Qi, Cardnell, Robert J., Rocha, Pedro, Fujimoto, Junya, Solis Soto, Luisa M., Wang, Runsheng, Novegil, Veronica, Ansell, Peter, He, Lei, Fernandez, Luisa, Jendrisak, Adam, Gilbertson, Cole, Schonhoft, Joseph D., Byun, Jiyun, Jones, Joshua, Anderson, Amanda K. L., Aparicio, Ana, Tran, Hai, Negrao, Marcelo V., Zhang, Jianjun, Wang, Wei-lien, Wistuba, Ignacio I., Wang, Jing, Wenstrup, Rick, Byers, Lauren A., and Gay, Carl M.

Published
2022
Full Text
View/download PDF

31. Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis

Author

Han, Hyunho, Wang, Yan, Curto, Josue, Gurrapu, Sreeharsha, Laudato, Sara, Rumandla, Alekya, Chakraborty, Goutam, Wang, Xiaobo, Chen, Hong, Jiang, Yan, Kumar, Dhiraj, Caggiano, Emily G., Capogiri, Monica, Zhang, Boyu, Ji, Yan, Maity, Sankar N., Hu, Min, Bai, Shanshan, Aparicio, Ana M., Efstathiou, Eleni, Logothetis, Christopher J., Navin, Nicholas, Navone, Nora M., Chen, Yu, and Giancotti, Filippo G.

Published
2022
Full Text
View/download PDF

34. Phase 1b study of tarlatamab in de novo or treatment-emergent neuroendocrine prostate cancer (NEPC).

Author

Aggarwal, Rahul Raj, primary, Rottey, Sylvie, additional, Bernard-Tessier, Alice, additional, Mellado-Gonzalez, Begoña, additional, Kosaka, Takeo, additional, Stadler, Walter Michael, additional, Sandhu, Shahneen, additional, Yu, Brian, additional, Shaw, Crystal, additional, Ju, Chia-Hsin, additional, Thompson, Corbin, additional, and Aparicio, Ana, additional

Published
2024
Full Text
View/download PDF

36. Supplementary Table S6 from Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series

Author

Anselmino, Nicolas, primary, Labanca, Estefania, primary, Shepherd, Peter D.A., primary, Dong, Jiabin, primary, Yang, Jun, primary, Song, Xiaofei, primary, Nandakumar, Subhiksha, primary, Kundra, Ritika, primary, Lee, Cindy, primary, Schultz, Nikolaus, primary, Zhang, Jianhua, primary, Araujo, John C., primary, Aparicio, Ana M., primary, Subudhi, Sumit K., primary, Corn, Paul G., primary, Pisters, Louis L., primary, Ward, John F., primary, Davis, John W., primary, Vazquez, Elba S., primary, Gueron, Geraldine, primary, Logothetis, Christopher J., primary, Futreal, Andrew, primary, Troncoso, Patricia, primary, Chen, Yu, primary, and Navone, Nora M., primary

Published
2024
Full Text
View/download PDF

37. Data from Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series

Author

Anselmino, Nicolas, primary, Labanca, Estefania, primary, Shepherd, Peter D.A., primary, Dong, Jiabin, primary, Yang, Jun, primary, Song, Xiaofei, primary, Nandakumar, Subhiksha, primary, Kundra, Ritika, primary, Lee, Cindy, primary, Schultz, Nikolaus, primary, Zhang, Jianhua, primary, Araujo, John C., primary, Aparicio, Ana M., primary, Subudhi, Sumit K., primary, Corn, Paul G., primary, Pisters, Louis L., primary, Ward, John F., primary, Davis, John W., primary, Vazquez, Elba S., primary, Gueron, Geraldine, primary, Logothetis, Christopher J., primary, Futreal, Andrew, primary, Troncoso, Patricia, primary, Chen, Yu, primary, and Navone, Nora M., primary

Published
2024
Full Text
View/download PDF

38. Supplementary Figure S4 from Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series

Author

Anselmino, Nicolas, primary, Labanca, Estefania, primary, Shepherd, Peter D.A., primary, Dong, Jiabin, primary, Yang, Jun, primary, Song, Xiaofei, primary, Nandakumar, Subhiksha, primary, Kundra, Ritika, primary, Lee, Cindy, primary, Schultz, Nikolaus, primary, Zhang, Jianhua, primary, Araujo, John C., primary, Aparicio, Ana M., primary, Subudhi, Sumit K., primary, Corn, Paul G., primary, Pisters, Louis L., primary, Ward, John F., primary, Davis, John W., primary, Vazquez, Elba S., primary, Gueron, Geraldine, primary, Logothetis, Christopher J., primary, Futreal, Andrew, primary, Troncoso, Patricia, primary, Chen, Yu, primary, and Navone, Nora M., primary

Published
2024
Full Text
View/download PDF

39. Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1

Author

Crawford, E. David, primary, Bryce, Alan H., additional, Hussain, Maha H., additional, Agarwal, Neeraj, additional, Beltran, Himisha, additional, Cooperberg, Matthew R., additional, Petrylak, Daniel P., additional, Shore, Neal, additional, Spratt, Daniel E., additional, Tagawa, Scott T., additional, Antonarakis, Emmanuel S., additional, Aparicio, Ana M., additional, Armstrong, Andrew J., additional, Boike, Thomas P., additional, Calais, Jeremie, additional, Carducci, Michael A., additional, Chapin, Brian F., additional, Cookson, Michael S., additional, Davis, John W., additional, Dorff, Tanya, additional, Eggener, Scott E., additional, Feng, Felix Y., additional, Gleave, Martin, additional, Higano, Celestia, additional, Iagaru, Andrei, additional, Morgans, Alicia K., additional, Morris, Michael, additional, Murray, Katie S., additional, Poage, Wendy, additional, Rettig, Matthew B., additional, Sartor, Oliver, additional, Scher, Howard I., additional, Sieber, Paul, additional, Small, Eric, additional, Srinivas, Sandy, additional, Yu, Evan Y., additional, Zhang, Tian, additional, and Koo, Phillip J., additional

Published
2024
Full Text
View/download PDF

40. Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2

Author

Bryce, Alan H., primary, Crawford, E. David, additional, Agarwal, Neeraj, additional, Hussain, Maha H., additional, Beltran, Himisha, additional, Cooperberg, Matthew R., additional, Petrylak, Daniel P., additional, Shore, Neal, additional, Spratt, Daniel E., additional, Tagawa, Scott T., additional, Antonarakis, Emmanuel S., additional, Aparicio, Ana M., additional, Armstrong, Andrew J., additional, Boike, Thomas P., additional, Calais, Jeremie, additional, Carducci, Michael A., additional, Chapin, Brian F., additional, Cookson, Michael S., additional, Davis, John W., additional, Dorff, Tanya, additional, Eggener, Scott E., additional, Feng, Felix Y., additional, Gleave, Martin, additional, Higano, Celestia, additional, Iagaru, Andrei, additional, Morgans, Alicia K., additional, Morris, Michael, additional, Murray, Katie S., additional, Poage, Wendy, additional, Rettig, Matthew B., additional, Sartor, Oliver, additional, Scher, Howard I., additional, Sieber, Paul, additional, Small, Eric, additional, Srinivas, Sandy, additional, Yu, Evan Y., additional, Zhang, Tian, additional, and Koo, Phillip J., additional

Published
2024
Full Text
View/download PDF

43. A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer

Author

Spetsieris, Nicholas, Boukovala, Myrto, Weldon, Justin A., Tsikkinis, Alexandros, Hoang, Anh, Aparicio, Ana, Tu, Shi-Ming, Araujo, John C., Zurita, Amado J., Corn, Paul G., Pagliaro, Lance, Kim, Jeri, Wang, Jennifer, Subudhi, Sumit K., Tannir, Nizar M., Logothetis, Christopher J., Troncoso, Patricia, Wang, Xuemei, Wen, Sijin, and Efstathiou, Eleni

Published
2021
Full Text
View/download PDF

45. Phase II study of the histone deacetylase inhibitor vorinostat (Suberoylanilide Hydroxamic Acid; SAHA) in recurrent or metastatic transitional cell carcinoma of the urothelium – an NCI-CTEP sponsored: California Cancer Consortium trial, NCI 6879

Author

Quinn, David I., Tsao-Wei, Denice D., Twardowski, Przemyslaw, Aparicio, Ana M., Frankel, Paul, Chatta, Gurkamal, Wright, John J., Groshen, Susan G., Khoo, Stella, Lenz, Heinz-Josef, Lara, Primo N., Gandara, David R., and Newman, Edward

Published
2021
Full Text
View/download PDF

47. Buenas Prácticas en la Atención a Familiares y Allegados en Casos de Desaparición de Personas. La Importancia del Profesional de la Psicología Especializado en Desapariciones.

Author

Isabel Álvarez-Aparicio, Ana, Martínez Fernández, José María, Acinas Acinas, María Patricia, and Herráez-Collado, Elena

Subjects
*MISSING persons, *PSYCHOTHERAPY, *BEST practices, *RELATIVES, *DATABASES
Abstract

Each year, an average of 23,000 missing persons reports are filed in Spain. Although most of them are resolved in the first few days, a significant number of people remain in the databases for years. The impact of a disappearance at all levels is not limited to the missing person's immediate environment but extends to different groups-professionals, community, and society-with a particular impact on family members and relatives. Best practices in the assistance provided to the latter are crucial due to the associated benefits. The role of the psychology professional, specialized in disappearances, is essential in the areas of prevention, intervention, and postvention. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

49. A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer

Author

Boukovala, Myrto, Spetsieris, Nicholas, Weldon, Justin A., Tsikkinis, Alexandros, Hoang, Anh, Aparicio, Ana, Tu, Shi-Ming, Araujo, John C., Zurita, Amado J., Corn, Paul G., Pagliaro, Lance, Kim, Jeri, Wang, Jennifer, Subudhi, Sumit K., Tannir, Nizar M., Logothetis, Christopher J., Troncoso, Patricia, Wen, Sijin, and Efstathiou, Eleni

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results